Precigen, Inc. (PGEN)

Name: Precigen, Inc. (PGEN) annual fundamentals
Creator: TickerFacts
License: https://creativecommons.org/publicdomain/zero/1.0/

Build a valuation ↗↓ Download CSV

SEC name PRECIGEN, INC. · CIK 0001356090 · Nasdaq · Pharmaceutical Preparations

Sector Manufacturing
Incorporated VA
Fiscal year ends Dec 31

For the year ended 2025-12-31, Precigen, Inc. reported revenue of $9.68M. Revenue grew 146.7% from the prior annual period. Over the twelve months to 2026-06-30, revenue was $85.72M.

Key ratios (year ended 2025-12-31)

n/m

Operating margin

n/m

Net margin

n/m

Return on year-end equity

146.7%

Revenue growth (YoY)

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 4 (ownership change) · 2026-09-24

Headquarters locality: Germantown · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-06-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period ended	TTM to 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31
Revenue	$85.72M	$9.68M	$3.92M	$6.22M	$26.91M	$14.27M	$31.99M	$90.72M	$151.18M	$219.46M	$190.93M
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	$33.26M	$37.71M
Gross Profit (computed)	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	$186.20M	$153.22M
R&D Expense	$32.29M	$41.33M	$53.07M	$48.61M	n/a	n/a	n/a	n/a	$404.59M	$143.21M	$112.14M
Operating Income	-$39.50M	-$110.51M	-$135.03M	-$99.76M	n/a	n/a	n/a	n/a	-$505.61M	-$137.89M	-$125.17M
Depreciation & Amortization	$4.14M	$3.20M	$4.53M	$6.67M	$10.77M	$13.76M	$17.52M	$24.90M	$33.11M	$31.14M	$24.57M
EBITDA	-$35.36M	-$107.31M	-$130.50M	-$93.09M	n/a	n/a	n/a	n/a	-$472.50M	-$106.75M	-$100.59M
Net Income	-$157.71M	-$250.64M	-$126.23M	-$95.90M	$28.32M	-$92.17M	-$170.52M	-$322.32M	-$509.34M	-$117.02M	-$186.61M
EPS (Diluted)	n/a	-$1.37	-$0.47	-$0.39	$0.14	-$0.47	-$1.02	-$2.09	n/a	n/a	n/a
Total Assets	$170.30M	$155.50M	$145.27M	$151.04M	$215.98M	$359.86M	$314.59M	$455.76M	$716.18M	$846.85M	$949.07M
Total Liabilities	$126.72M	$134.59M	$78.53M	$32.55M	$89.72M	$252.51M	$247.41M	$384.05M	$337.45M	$300.31M	$379.82M
Long-Term Debt	$93.88M	$93.17M	$0	n/a	$43.22M	$179.93M	$171.88M	$217.99M	$211.69M	$8.04M	$7.95M
Shareholders' Equity	$43.58M	$20.91M	$38.51M	$118.50M	$126.26M	$107.35M	$67.17M	$71.71M	$362.86M	$533.63M	$560.24M
Cash & Equivalents	$16.33M	$30.23M	$29.52M	$7.58M	$4.86M	$36.42M	$51.79M	$65.79M	$96.88M	$68.11M	$62.61M
Operating Cash Flow	-$114.17M	-$87.83M	-$68.17M	-$66.93M	-$65.05M	-$55.77M	-$77.02M	-$135.93M	-$124.24M	-$103.72M	-$48.99M
Capital Expenditures	$1.06M	$2.00M	$8.58M	$1.54M	$4.92M	$7.25M	$7.53M	$37.88M	$41.59M	$46.67M	$31.63M
Free Cash Flow	-$115.22M	-$89.83M	-$76.76M	-$68.47M	-$69.97M	-$63.02M	-$84.55M	-$173.81M	-$165.83M	-$150.39M	-$80.62M
Shares Outstanding	358.01M	353.91M	292.87M	248.92M	208.15M	206.74M	187.66M	163.27M	160.02M	122.09M	118.69M
Weighted Average Diluted Shares	n/a	312.98M	267.73M	244.54M	200.36M	197.76M	167.07M	154.14M	n/a	n/a	n/a
EPS (Basic)	n/a	-$1.37	-$0.47	-$0.39	$0.14	-$0.47	-$1.02	-$2.09	n/a	n/a	n/a

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView